Innate Pharma SA announced that it has obtained 28.7 Million in non-dilutive financing in the form of two loans from Société Générale and BNP Paribas. The two loans have an initial term of one year with a five-year extension option. They are 90% guaranteed by the French state as part of the package of measures put in place by the French government to support companies during the COVID-19 pandemic.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
2.19 EUR | -0.68% | -3.10% | -16.41% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.41% | 190M | |
+19.35% | 42.68B | |
-2.17% | 42.4B | |
+45.21% | 40.04B | |
-6.20% | 28.31B | |
+6.75% | 24.94B | |
-21.25% | 18.96B | |
+30.40% | 12.3B | |
-2.67% | 11.95B | |
-3.53% | 11.55B |
- Stock Market
- Equities
- IPH Stock
- News Innate Pharma
- Innate Pharma S.A. Obtains €28.7 Million in Non-Dilutive Financing in the Form of State Guaranteed Loans